Related references
Note: Only part of the references are listed.Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Efficacy and Safety of Transarterial Chemoembolization Plus External Beam Radiotherapy vs Sorafenib in Hepatocellular Carcinoma With Macroscopic Vascular Invasion A Randomized Clinical Trial
Sang Min Yoon et al.
JAMA ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Stereotactic body radiotherapy based treatment for hepatocellular carcinoma with extensive portal vein tumor thrombosis
Yongjie Shui et al.
RADIATION ONCOLOGY (2018)
Efficacy of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis/inferior vena cava tumor thrombosis: evaluation by comparison with conventional three-dimensional conformal radiotherapy
Yoshiro Matsuo et al.
JOURNAL OF RADIATION RESEARCH (2016)
Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis
Takahide Nakazawa et al.
BMC GASTROENTEROLOGY (2014)
The feasibility of combined transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma
Ju-Yeon Cho et al.
LIVER INTERNATIONAL (2014)
Radiotherapeutic Options for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
Dong Soo Lee et al.
LIVER CANCER (2014)
Stereotactic body radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombosis
Jingbo Kang et al.
MOLECULAR AND CLINICAL ONCOLOGY (2014)
Transcatheter arterial chemoembolization and radiation therapy for treatment-naive patients with locally advanced hepatocellular carcinoma
Sang Won Kim et al.
RADIATION ONCOLOGY JOURNAL (2014)
Effectiveness of Stereotactic Body Radiotherapy for Hepatocellular Carcinoma with Portal Vein and/or Inferior Vena Cava Tumor Thrombosis
Mian Xi et al.
PLOS ONE (2013)
RADIOTHERAPY PLUS TRANSARTERIAL CHEMOEMBOLIZATION FOR HEPATOCELLULAR CARCINOMA INVADING THE PORTAL VEIN: LONG-TERM PATIENT OUTCOMES
Sangmin Yoon et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Preserved liver function, portal thrombosis and absence of oesophageal varices are risk factors for metastasis of hepatocellular carcinoma
Luigi Addario et al.
DIGESTIVE AND LIVER DISEASE (2011)
Prognostic Index for Portal Vein Tumor Thrombosis in Patients with Hepatocellular Carcinoma Treated with Radiation Therapy
Jeong Il Yu et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2011)
Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
Riccardo Lencioni et al.
SEMINARS IN LIVER DISEASE (2010)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Prognostic factors for patients with hepatocellular carcinoma with macroscopic portal vein or inferior vena cava tumor thrombi receiving external-beam radiation therapy
Zhao-Chong Zeng et al.
CANCER SCIENCE (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Conformal radiation therapy for portal vein tumor thrombosis of hepatocellular carcinoma
Ryo Toya et al.
RADIOTHERAPY AND ONCOLOGY (2007)
Potential prognostic benefits of radiotherapy as an initial treatment for patients with unresectable advanced hepatocellular carcinoma with invasion to intrahepatic large vessels
Takahide Nakazawa et al.
ONCOLOGY (2007)
Three-dimensional conformal radiotherapy of unresectable hepatocellular carcinoma patients for whom transcatheter arterial chemoembolization was ineffective or unsuitable
Tae Hyun Kim et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2006)
Partial volume tolerance of the liver to radiation
LA Dawson et al.
SEMINARS IN RADIATION ONCOLOGY (2005)
Three-dimensional conformal radiotherapy for portal vein thrombosis of hepatocellular carcinoma
DY Kim et al.
CANCER (2005)
Prospective trial of combined transcatheter arterial chemoembolization and three-dimensional conformal radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma
K Yamada et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2003)
Radiotherapy after transcatheter arterial chemoembolization for patients with hepatocellular carcinoma and portal vein tumor thrombus
S Ishikura et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2002)
Radiation therapy in combination with transcatheter arterial chemoembolization for hepatocellular carcinoma with extensive portal vein involvement
J Tazawa et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2001)
Share Paper
